Treating Medical Inflation as a Boardroom Priority: Byron Beebe on rethinking workforce costs

In a region where healthcare costs are rising faster than wages, the impact of medical inflation is no longer just an HR challenge—it’s a boardroom imperative. Leading employers across Asia are grappling with a new reality: unchecked medical inflation threatens not only the bottom line but also the ability to invest in talent, skills, and long-term growth.

In this exclusive People Matters interview, Byron Beebe, CEO of Human Capital for Aon, unpacks the macroeconomic risks of unchecked medical inflation and challenges conventional thinking about workforce cost management. He shares data-driven insights, practical strategies, and real-world examples of how leading employers are reframing health benefits as strategic assets rather than expenses. From leveraging analytics to inform boardroom decisions, to balancing cost control with investment in talent, Beebe lays out a bold roadmap for CHROs and business leaders navigating today’s complex environment. Edited excerpts

Medical inflation in Southeast Asia is outpacing general inflation and, in many markets, wage growth. Over time, that shifts healthcare from a cyclical benefits issue to a structural cost embedded in an organisation's operating model.

For boards, the implication is clear. When healthcare costs rise faster than inflation, they gradually erode headroom available for salaries, skills and growth. Treating medical inflation as a macroeconomic cost risk puts it in the same conversation as wages, energy, and capital allocation, encouraging leaders to plan over a three- to five-year horizon, not one renewal at a time.

In our work with boards and executive teams, we typically start by clarifying their exposure by market and workforce segment, and how that compares to peers. From there, the discussion naturally shifts away from this year’s increase towards the mix of governance, plan design, and prevention needed to keep costs predictable while still attracting and retaining a healthy, productive workforce.

From your vantage point as an advisor to global employers, how are sustained healthcare cost pressures reshaping workforce strategy, particularly in areas such as talent acquisition, retention, skills investment, and flexible work models?

Sustained pressure on healthcare costs is forcing organisations to re-examine how they use their total workforce budget. Over the past two decades, global  increases in health costs have changed the way organisations think about spending on retirement benefits.  Now, additional health care spending is competing with other priorities such as base pay, incentives, learning and headcount, particularly in talent-intensive markets.

In response, many employers are taking a more integrated view of total rewards and workforce strategy. Rather than adding benefits incrementally, they are asking harder questions about which elements genuinely attract and retain their workforce, and which deliver limited value because they are poorly understood or underused. That often leads to more focused health and wellbeing offerings, different balances between fixed and variable rewards, and, in some cases, new approaches to where and how work is done.

Our role in those conversations is to connect the data — healthcare costs, pay, skills, and location — and help leaders understand what different choices mean over time. When healthcare is assessed alongside these other levers, organisations are better positioned to make deliberate trade-offs rather than react year by year to cost pressures.

What are the unique challenges and vulnerabilities facing Asia-based employers when it comes to medical inflation, especially considering demographic trends, high medical utilisation, and the prevalence of employer-sponsored healthcare?

Asia-based employers are contending with a distinctive set of dynamics: ageing populations in several markets, high utilisation of private healthcare, and a strong reliance on employer-sponsored coverage as the primary route to care for much of the workforce. Aon’s 2026 Global Medical Trends Rate Report shows Asia-Pacific with the highest projected gross medical trend of any region at 11.3 percent, and a net trend of 8.9 percent after general inflation. The implication is that healthcare can continue to rise even as broader economic conditions soften.

Large employers also operate across a wide range of healthcare systems and regulatory environments within the region. While the report highlights that a small number of APAC markets expect modest easing in trend, roughly two-thirds continue to face upward pressure from ageing, chronic disease and increased utilisation. Over time, this often results in a patchwork of plan designs, funding approaches and vendors that are difficult to compare, govern and manage as a whole. It can obscure where costs are accelerating fastest, where benefits are out of line with the market, or where employees may not be well served.

The most effective starting point is usually diagnostic: understanding where money is being spent, what is driving the trend in each market, and how that aligns with workforce needs. With that clarity, leadership teams can make informed decisions about where greater consistency adds value, where local variation is justified, and what level of governance and data is required to reduce volatility while maintaining a credible employee proposition.

Could you share examples or data points that illustrate how medical inflation is directly impacting business productivity and total rewards strategies for multinational organisations?

Medical inflation is shaping organisational decisions on two fronts at once: cost and capacity. On the cost side, rising healthcare spend reduces flexibility across the total rewards budget — constraining pay progression, long-term incentives and the ability to invest in technology and skills. On the capacity side, unmanaged health risks show up as higher absence, presenteeism and burnout, with direct implications for productivity and engagement.

As a result, many multinationals are moving beyond a narrow focus on limits and reimbursement levels. Instead, they are placing greater emphasis on prevention, early intervention and helping employees navigate to appropriate care, because these levers influence both cost trends and how effectively people can work. Aon’s report reinforces this point, highlighting cardiovascular disease, cancer, hypertension and diabetes as leading drivers of medical plan costs, alongside risk factors such as obesity and physical inactivity.

In our work, we bring together claims data, utilisation patterns and workforce demographics to show where health risks and costs are most concentrated. That evidence then supports decisions on plan design, care pathways, and wellbeing investment, directing spend toward areas that improve workforce performance over time rather than simply increasing headline levels of cover.

Forward-looking organisations are increasingly treating health and benefits as a managed risk portfolio. Rather than waiting for renewal, they are using data and analytics to anticipate where pressure is likely to emerge and which segments of the workforce are most exposed. Aon’s report highlights that a small set of conditions — cardiovascular disease, cancer, hypertension and diabetes — are expected to remain among the top global drivers of medical plan costs in 2026. In some markets, newer therapies such as GLP1s are also beginning to account for a meaningful share of medical trend, reinforcing the need for earlier visibility and control.

In practice, this approach involves integrating claims, utilisation, and demographic data, and, where possible, linking them to workforce outcomes. With that level of insight, leaders can identify patterns, such as emerging chronic conditions within specific cohorts, overreliance on certain providers, or underutilisation of preventive services. It also allows organisations to model the likely impact of different plan designs, funding approaches or wellbeing initiatives before making material changes.

Balancing cost control with meaningful health and wellbeing benefits starts with recognising that not all benefit spend delivers the same return. The objective is not to spend less on health, but to spend more effectively. Increasingly, employers are shifting the question from “How do we cut?” to “Are we getting enough value from what we already spend?” Aon’s insights show that organisations striking this balance focus on smarter plan design, flexibility and prevention, rather than blunt cost-cutting measures.

In practice, this typically translates into three areas of action. First, refining plan design and provider networks so care is delivered in the right settings, and high-cost areas are managed thoughtfully. Second, introducing greater choice or flexibility allows benefits to better align with different life stages without simply layering on additional cost. Third, strengthening communication and navigation so employees understand what is available to them and how to access it effectively.

When we work with organisations on these issues, the focus is usually on rebalancing rather than wholesale reduction — redirecting spend away from low-value areas and towards benefits and services that employees notice and that support better health outcomes. Done well, this approach can enhance the perceived value of the overall package while keeping cost growth on a more manageable path.

Are there emerging models or innovative approaches in Asia or globally that you believe will redefine how employers address healthcare cost pressures in the coming years?

There is no single model that will resolve healthcare cost pressures, but the direction of travel is clear. Globally and across Asia, employers are moving towards more modular benefit structures, greater use of alternative funding approaches and an expanding role for digital health and data-driven decision-making. These responses align closely with the report’s findings, which point to higher utilisation, advanced medical technologies and growing demand for private healthcare as key cost drivers.

In practice, this shows up in different ways. Some organisations are tailoring plan design more explicitly by workforce segment, supported by risk-sharing arrangements and stronger controls around fraud, waste and abuse. Others are using digital tools to guide employees toward primary and preventive care earlier, reducing the likelihood and cost of more complex interventions later on. As these programs are implemented, it is important to continue monitoring return on investment and capture data that can be fed into predictive analytics tools to provide greater cost certainty going forward.

Our experience is that these approaches deliver the greatest impact when built on solid fundamentals: high-quality data, clear governance and a realistic understanding of employee needs. Advisers and insurers can bring ideas and technology, but organisations see the most value when health is managed as part of a broader workforce and risk agenda rather than treated as a standalone benefits exercise.

For CHROs and boards in Southeast Asia that are beginning to treat medical inflation as a strategic issue, the first priority is to establish a shared fact base. That means understanding current spend, how quickly it is growing, how it compares with peers, and how it varies by market and workforce segment.

With that clarity, healthcare can be brought into the same board-level conversations as pay, skills and workforce planning. Leaders are then in a position to agree on a direction of travel: what level of cost growth is acceptable, how they want to balance coverage with prevention and flexibility, and over what time frame change could occur.

In our conversations with senior teams, we often frame this as a phased journey — diagnose, stabilise and then, where appropriate, transform. Starting with diagnostics and governance helps reduce the risk of unintended consequences and provides organisations with a clearer path to managing medical inflation that aligns with their broader talent and business strategy.